Abstract:The link between tumors and the hemostatic system, first of all platelets, has been acknowledged by numerous studies. Platelets activation at the tumor microenvironment and subsequent intravascular clotting are often associated with cancer complications. Recent clinical studies demonstrated that platelet inhibitors substantially decrease risk of tumor metastasis and mortality in cancer patients, thereby emphasizing clinical importance of platelets. However, the precise function of platelets in cancer progression remains enigmatic. Growing tumors secrete a plethora of growth factors and cytokines (tumor secretome) aiming to change its micro- and macro-environment. These factors promote angiogenesis, induce inflammation, and even stimulate changes in bones prior to metastasis. Tumor secretome signals are likely transmitted through the circulation; however, these signals need to be protected from degradation or utilization prior to reaching their target. Due to their ability to intake and secrete back a wide spectrum of proteins, platelets could function as a mobile storage compartment for the tumor secretome. Using platelet infusion and depletion during tumor growth, we assessed the role of platelets in tumor growth and tumor-induced bone remodeling. We demonstrated that platelet infusion stimulates communications between bone marrow and the tumor, while platelet depletion had the opposite effects. Importantly, tumor-induced changes in bone structure were completely abolished in the absence of platelets. Using platelets from knockout mice with various platelet defects, we demonstrated that platelet secretion (but not aggregation) was crucial for their function in tumor progression. In particular, the function of platelet α-granules is essential for the pro-tumorigenic role of platelets. Analysis of the tumor secretome revealed that 77 percent of tumor-secreted factors are highly enriched within platelets over plasma. Several of these factors are essential mediators of bone remodeling. Thus, our data show that platelet α-granule sequestration and secretion represent a cellular mechanism mediating communication between the bone microenvironment and the primary tumor.

Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy

Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy

Inhibition of Platelet Function: Does It Offer a Chance of Better Cancer Progression Control?

Inhibition of MCF-7 Breast Cancer Cell-Induced Platelet Aggregation Using a Combination of Antiplatelet Drugs.

Emerging roles of platelets in cancer biology and their potential as therapeutic targets

The dynamic role of platelets in cancer progression and their therapeutic implications

Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies

Platelet-inspired Medicine for Tumor Therapyplatelet-Inspired Medicine for Tumor Therapy

Recent advances in platelet engineering for anti-cancer therapies

Role of Platelet Activation in the Development and Metastasis of Solid Tumors

Engineered Platelets for Cancer Therapy

Platelet-Leukocyte Interplay in Cancer Development and Progression

Role of platelets in inflammation and cancer: novel therapeutic strategies

Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-Selectin

Platelets and the Tumor Cell Microenvironment

The use of platelets as a clinical tool in oncology: opportunities and challenges

The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis

Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets

Platelets and circulating (tumor) cells: partners in promoting metastatic cancer

Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis

Cancer Cell-Derived Immunoglobulin G Activates Platelets by Binding to Platelet FcγRIIa